Biocon is in the midst of Cycle wave 3, consequently we have seen solid momentum since early 2016 in this stock. Hopefully, the EW counts are self explanatory. We should see a pause to the rally in the short term.Traders should short the scrip for targets below 1000 (possibly upto 900). Investors can accumulate in 800-900 range.
Note: This post is only for education purposes and not a recommendation to buy or sell.